ACS Medicinal Chemistry Letters p. 543 - 547 (2015)
Update date:2022-07-29
Topics:
Li, Yingjun
Cheng, Huimin
Zhang, Zhang
Zhuang, Xiaoxi
Luo, Jinfeng
Long, Huoyou
Zhou, Yang
Xu, Yong
Taghipouran, Rana
Li, Dan
Patterson, Adam
Smaill, Jeff
Tu, Zhengchao
Wu, Donghai
Ren, Xiaomei
Ding, Ke
A series of N-(3-ethynyl-2,4-difluorophenyl)sulfonamides were identified as new selective Raf inhibitors. The compounds potently inhibit B-RafV600E with low nanomolar IC50 values and exhibit excellent target specificity in a selectivity profiling investigation against 468 kinases. They strongly suppress proliferation of a panel of human cancer cell lines and patient-derived melanoma cells with B-RafV600E mutation while being significantly less potent to the cells with B-RafWT. The compounds also display favorable pharmacokinetic properties with a preferred example (3s) demonstrating significant in vivo antitumor efficacy in a xenograft mouse model of B-RafV600E mutated Colo205 human colorectal cancer cells, supporting it as a promising lead compound for further anticancer drug discovery.
View Morewebsite:https://www.sinoshiny.com/products
Contact:+86-20-62802632;62802633
Address:Room 330 GIGCAS Building,No.511 Kehua Street,Tianhe District
Contact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Jinan Hongfangde Pharmatech Co.,Ltd
Contact:86-531-88870908
Address:F Bldg. West Unit North Area of Univ. Tech. Garden Xinyu Rd. Jinan New & High Tech Industry Development Zone Shandong, China
Contact:+1-973-357-0577
Address:10 Taft Rd.
Lishui Nanming Chemical Co., Ltd(expird)
Contact:+86-0578-2134101,2697830
Address:No.19 Tongji Road Shuige Industrial zone
Doi:10.1007/s11164-012-0654-2
(2013)Doi:10.1002/ejic.201101189
(2012)Doi:10.1007/BF01164718
(1996)Doi:10.1016/0022-328X(91)80073-S
(1991)Doi:10.1021/ja00079a010
(1993)Doi:10.1002/jhet.3557
(2019)